Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Bayer
Jonathan P Piccini; Valeria Caso; Stuart J Connolly; Keith A A Fox; Jonas Oldgren; W Schuyler Jones; Diana A Gorog; Václav Durdil; Thomas Viethen; Christoph Neumann; Hardi Mundl; Manesh R Patel; PACIFIC-AF Investigators